According to Janux Therapeutics's latest financial reports the company's current EPS (TTM) is -1,55ย โฌ. In 2022 the company made an earnings per share (EPS) of -1,45ย โฌ a decrease over its 2021 EPS that were of -1,21ย โฌ.